The World Hepatitis Summit is a large-scale, global biennial event with the goal of advancing the viral hepatitis agenda. It is a joint initiative between World Health Organization (WHO) and the World Hepatitis Alliance.
Francisco Viegas Neves da Silva, Regional Policy Advocacy Consultant, DNDi Latin America, presented on the DNDi strategy on access to hepatitis C treatment.
Advocacy for access to hepatitis treatment
Date: Thursday, November 2, 2017
Chairs: Jennifer Johnston, CEVHAP and Bobby John, Global Health Advocates, India
Introduction and vision
Advocacy for access for the most vulnerable populations
|Brazilian experience on patent opposition|
Felipe de Carvalho, Working Group on Intellectual Property of the Brazilian Network for the Integration of Peoples (GTPI/Rebrip)
DNDi strategy on access to hepatitis C medicines
Role of the civil society: case study in a country with access to generics